Thalidomide-NH-cyclohexane-NH-Ph-NH2
Thalidomide-NH-cyclohexane-NH-Ph-NH2 is an E3 Ligase Ligand-Linker Conjugate. Thalidomide-NH-cyclohexane-NH-Ph-NH2 can be used to synthesize PROTAC erf3a Degrader-2.
Product Specifications
UNSPSC
12352005
Target
E3 Ligase Ligand-Linker Conjugates
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/thalidomide-nh-cyclohexane-nh-ph-nh2.html
Smiles
O=C(C1=CC=CC(N[C@@H]2CCC[C@@H](NC3=CC(N)=CC=C3)C2)=C1C4=O)N4C5C(NC(CC5)=O)=O
Molecular Formula
C25H27N5O4
Molecular Weight
461.51
References & Citations
[1]Drug for treating human tumor by erf3a targeted protein degradation mechanism. China, CN117801051 A. 2024-04-02.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940352-500 1x 500 µL
CD31 / PECAM-1 (158-2B3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680050-500 1x 500 µL
IgA Secretory Component (SC05), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470493-100 1x 100 µL
Moesin (MSN/493), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881139-100 1x 100 µL
CD66, pan (CEA) (Cocktail), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details